Solventum (SOLV) Net Income towards Common Stockholders (2023 - 2026)
Solventum (SOLV) posted Net Income towards Common Stockholders of $13.0 million for Q1 2026, down 79.37% on a QoQ basis from $63.0 million in Q4 2025, and down 90.51% year-over-year from $137.0 million in Q1 2025.
Solventum (SOLV) Net Income towards Common Stockholders (2023 - 2026) Analysis & Trends
Solventum's Net Income towards Common Stockholders history runs 4 years deep, the most recent figure standing at $13.0 million for Q1 2026.
- Quarterly Net Income towards Common Stockholders fell 90.51% year-over-year to $13.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 billion (up 278.84% YoY) and the FY2025 annual result came in at $1.6 billion, up 225.52% from the prior year.
- Net Income towards Common Stockholders was $13.0 million for Q1 2026 at Solventum, down from $63.0 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $1.3 billion in Q3 2025 and bottomed at $13.0 million in Q1 2026.
- A 4-year average of $261.0 million and a median of $137.0 million in 2025 frame the typical range for Net Income towards Common Stockholders.
- Annual changes were most pronounced in 2025 — Net Income towards Common Stockholders soared 937.7% — and 2026, when it tumbled 90.51%.
- Solventum's Net Income towards Common Stockholders stood at $272.0 million in 2023, then sank by 88.97% to $30.0 million in 2024, then surged by 110.0% to $63.0 million in 2025, then sank by 79.37% to $13.0 million in 2026.
- Business Quant data shows SOLV's Net Income towards Common Stockholders at $13.0 million in Q1 2026, $63.0 million in Q4 2025, and $1.3 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 33,163,703.85 Bn | 33,163,702.19 Bn | 1.53 Bn | 22.13 Bn |
| 2 | Intuitive Surgical | 119.67 Bn | 114.45 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Becton Dickinson | 43.92 Bn | 43.11 Bn | 2.15 Bn | -274.00 Mn |
| 4 | Medline | 31.71 Bn | 29.47 Bn | 1.84 Bn | 239.00 Mn |
| 5 | Resmed | 28.46 Bn | 26.80 Bn | 890.98 Mn | 398.73 Mn |
| 6 | West Pharmaceutical Services | 23.80 Bn | 23.28 Bn | 296.40 Mn | 135.40 Mn |
| 7 | Cooper Companies | 13.77 Bn | 13.63 Bn | 735.40 Mn | -77.90 Mn |
| 8 | Solventum | 13.63 Bn | 13.06 Bn | 1.10 Bn | 13.00 Mn |
| 9 | Align Technology | 11.94 Bn | 10.88 Bn | 736.59 Mn | 112.77 Mn |
| 10 | Baxter International | 11.56 Bn | 9.54 Bn | 891.00 Mn | 2.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.00 Mn |
| Dec 31, 2025 | 63.00 Mn |
| Sep 30, 2025 | 1.27 Bn |
| Jun 30, 2025 | 90.00 Mn |
| Mar 31, 2025 | 137.00 Mn |
| Dec 31, 2024 | 30.00 Mn |
| Sep 30, 2024 | 122.00 Mn |
| Jun 30, 2024 | 89.00 Mn |
| Mar 31, 2024 | 237.00 Mn |
| Dec 31, 2023 | 272.00 Mn |
| Sep 30, 2023 | 460.00 Mn |
| Jun 30, 2023 | 321.00 Mn |
| Mar 31, 2023 | 293.00 Mn |